Search clinical trials for: Pyrotinib, Trastuzumab, Docetaxel
Total 3280 results
-
Azaya Therapeutics, Inc.CompletedBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Solid Tumor | Non-Small Cell LungUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityUnknownHER2-positive Breast Cancer
-
Shengjing HospitalRecruiting
-
Sunshine Lake Pharma Co., Ltd.Not yet recruitingEsophageal Cancer | Advanced Solid TumorChina
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingBreast Ductal Carcinoma In SituUnited States, Canada, Puerto Rico, Korea, Republic of
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
Eric Winer, MDMassachusetts General Hospital; Yale University; Dana-Farber Cancer Institute; Beth... and other collaboratorsCompletedBreast CancerUnited States
-
Fudan UniversityNot yet recruiting
-
Hoffmann-La RocheCompletedBreast CancerItaly, Spain, China, Taiwan, Russian Federation, Canada, Germany, Austria, Hungary, Belgium, Australia, Brazil, Mexico, Poland, Panama
-
Korean Breast Cancer Study GroupUnknownMetastatic Breast Cancer | Recurrent Breast CancerKorea, Republic of
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Early-stage Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
Sunshine Lake Pharma Co., Ltd.Completed
-
University of RochesterSuspendedHER2-positive Breast CancerUnited States
-
Hoffmann-La RocheCompletedBreast NeoplasmsCanada, United States, France, Korea, Republic of, Spain, Belgium, Germany, Russian Federation, Taiwan, Ukraine
-
Qilu Pharmaceutical Co., Ltd.Completed
-
Shanghai Jiao Tong University School of MedicineJiangsu HengRui Medicine Co., Ltd.Active, not recruitingBreast Cancer InvasiveChina
-
The First Affiliated Hospital of Zhengzhou UniversityRecruiting
-
Cancer Institute and Hospital, Chinese Academy...Completed
-
Hoffmann-La RocheCompletedBreast CancerItaly, Korea, Republic of, Spain, Taiwan, United Kingdom, Brazil, Russian Federation, Thailand, Israel, Turkey, Austria, Canada, Poland, Sweden, Australia, Peru, Switzerland, Mexico
-
Spanish Breast Cancer Research GroupCompleted
-
Fudan UniversityHoffmann-La RocheUnknown
-
German Breast GroupAGO Study GroupCompleted
-
Jiangsu HengRui Medicine Co., Ltd.CompletedHealthy ParticipantsChina
-
Shanghai JMT-Bio Inc.Not yet recruitingFirst-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer
-
Hoffmann-La RocheRecruitingLocally Advanced or Metastatic Breast CancerFrance, Belgium, United States, Korea, Republic of, Taiwan, Brazil, China, Italy, Argentina, Jordan, Mexico, Germany, Portugal, Spain, Thailand, Turkey, United Kingdom, Kenya, Hungary, Poland, Colombia, India, Oman, Uganda, United Arab... and more
-
Tianjin Medical University Cancer Institute and...Enrolling by invitationRecurrent/Refractory Classical Hodgkin's LymphomaChina
-
Peking UniversityActive, not recruitingGastric AdenocarcinomaChina
-
SCRI Development Innovations, LLCGlaxoSmithKline; Aventis PharmaceuticalsCompleted
-
National Cancer Institute, NaplesWithdrawn
-
Orano Med LLCCompletedStomach Neoplasms | Breast Neoplasms | Pancreatic Neoplasms | Ovarian Neoplasms | Peritoneal NeoplasmsUnited States
-
CinnagenCompletedHER2-positive Breast CancerIran, Islamic Republic of
-
National Cancer Institute (NCI)Active, not recruitingMale Breast Carcinoma | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States, Puerto Rico
-
Samsung Bioepis Co., Ltd.TerminatedBreast NeoplasmsUkraine, Romania, Russian Federation, France, Bulgaria, Czechia, Poland
-
University Medical Center GroningenCompleted
-
Qilu Pharmaceutical Co., Ltd.Completed
-
Hoffmann-La RocheCompletedBreast CancerKazakhstan, Belarus
-
Hoffmann-La RocheCompleted
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingHER2-expressing Advanced Solid TumorsChina
-
BiogenCompleted
-
Accelerated Community Oncology Research NetworkAventis PharmaceuticalsCompletedBreast NeoplasmUnited States
-
AstraZenecaDaiichi SankyoCompletedBreast CancerDenmark, Finland, Italy, Norway, Spain, Sweden, Poland, United States, Canada, Germany, Japan, Netherlands, Portugal, Switzerland, Australia, United Kingdom, Belgium, Ireland
-
PfizerCompleted
-
Jules Bordet InstituteHoffmann-La Roche; Breast International Group; Institut Curie; International Drug...SuspendedHER2-positive Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast Cancer | Node-negative Breast CancerKorea, Republic of, France, Israel, Belgium, Switzerland, Australia
-
Byondis B.V.CompletedEndometrial CancerKorea, Republic of, Singapore, Russian Federation, Ukraine, United States, Poland, Serbia
-
Translational Research Center for Medical Innovation...Completed
-
National Cancer Institute (NCI)CompletedCombination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast CancerStage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedT-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid TumorsSarcoma | Breast Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)TerminatedAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Breast Carcinoma | HER2-Positive Breast CarcinomaUnited States